Evotec SE EVO
NASDAQ EVO
$1.42 +0.08 (+5.95%)
At close: Oct 14, 2026 · 4:00 PM EDT

Evotec SE (EVO) Capital Leases (2009 - 2010)

Updated

Evotec SE (EVO) reported Capital Leases of $61,981 for the quarter ended Sep 30, 2010, down 32.5% from the prior quarter.

Analysis

Evotec SE (EVO) Capital Leases (2009 - 2010) Analysis & Trends

As of Dec 31, 2009, Evotec SE posted Capital Leases of $184,133.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn
7 Evotec SE 506.10 Mn -1.10 Bn -
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 65,414.70
Jun 30, 2010 88,056.17
Mar 31, 2010 145,886.80
Dec 31, 2009 189,117.18
Sep 30, 2009 227,152.83
Jun 30, 2009 284,988.27
Mar 31, 2009 364,291.48
API Access

Evotec SE Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=EVO&period=max&api_key=YOUR_API_KEY